Filing Details
- Accession Number:
- 0001104659-21-128067
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-20 16:14:32
- Reporting Period:
- 2021-10-19
- Accepted Time:
- 2021-10-20 16:14:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1724344 | Entasis Therapeutics Holdings Inc. | ETTX | Pharmaceutical Preparations (2834) | 824592913 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1751832 | Manoussos Perros | C/O Entasis Therapeutics Holdings Inc., 35 Gatehouse Drive Waltham MA 02451 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-10-19 | 79,750 | $0.00 | 159,500 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2021-10-19 | 11,974 | $3.19 | 147,526 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Acquired as a result of the satisfaction of the performance criteria of the underlying award as of the date stated. Fifty percent of this award vested on such date and the remaining fifty percent will vest on the first anniversary of such date, subject to the reporting person's continued employment with the Company.
- Represents shares sold solely for purposes of the payment of taxes arising in connection with the vesting of restricted stock units on October 19, 2021. The number of shares sold was determined based on the closing price on the last trading day prior to vesting, which was October 18, 2021.
Billionaire Hedge Funds
